Glioblastoma Market, an Area With High Trial Failure And Unmet Need is Expected to Witness Significant Growth Owing to Increased Usage of Bevacizumab, Temozolimide, Optune Gio Along with Emergence of New Class of Therapies | DelveInsight New York, USA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Glioblastoma Market, an Area With High Trial Failure And Unmet Need is Expected to Witness Significant Growth Owing to Increased Usage of...

Glioblastoma Multiforme Treatment (GBM) Market Research Report 2024-2030: Focus on Radiation Therapy, Surgery, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme Treatment (GBM) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...

Glioblastoma Pipeline Landscape Report 2024: Pivotal Advances in Treatment Protocols and Drug Developments Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Glioblastoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest report on the Glioblastoma pipeline...

Global Glioblastoma Multiforme (GBM) Industry Landscape, 2030 - Featuring Genentech, Merck, VBL Therapeutics, Diffusion Pharma, Bayer, and More Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme (GBM) - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. ...

Glioblastoma Pipeline Analysis | Clinical Trials Report 2021 by DelveInsight Los Angeles, USA, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Glioblastoma Pipeline Analysis | Clinical Trials Report 2021 | DelveInsight There are approximately 150+ key companies developing Glioblastoma...